Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
View Session Discussion + Q&A

Adult ID

HIV-STD-TB

Trainee
Session Type: Debate-Style Session

68 - Friendly Squabbles Among Friends

Monday, October 20, 2025
1:45 PM - 3:00 PM US ET
Location: B302-B304

Live Streamed On Demand
CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

    Debate Style Moderator(s)

  • Aadia Rana, MD (she/her/hers)

    Professor of Medicine
    University of Alabama-Birmingham School of Medicine
    Birmingham, AL, United States

  • Elizabeth Sherman, PharmD

    Associate Professor
    Division of Infectious Disease
    Nova Southeastern University
    Fort Lauderdale, FL, United States

    • Faculty(s)

  • CH

    Claudia Hawkins, MD, MPH

    Associate Professor of Medicine and Infectious Diseases
    Northwestern University Feinberg School of Medicine

  • DB

    Debika Bhattacharya, MD MSc

    Clinical Professor
    Medicine
    David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California
    Los Angeles, CA, United States

  • Christopher Evans, MD (he/him/his)

    Associate Professor of Medicine
    Oregon Health & Science University
    Portland, OR, United States

  • Barbara Taylor, MD, MS (she/her/hers)

    Professor
    UT San Antonio, Long School of Medicine
    San Antonio, TX, United States

Disclosure(s):
Aadia Rana, MD: No financial relationships to disclose.
Elizabeth M. Sherman, PharmD: No financial relationships to disclose.
Claudia Hawkins, MD, MPH: No financial relationships to disclose.
Debika Bhattacharya, MD MSc: Gilead Biosciences: Grant/Research Support
Christopher Evans, MD: GSK/ViiV Healthcare: Grant/Research Support
Barbara S. Taylor, MD, MS: Gilead Biosciences: I serve as a site investigator for a Gilead sponsored study.

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • evaluate the pros and cons for people with HIV of an HIV specialist versus a generalist serving as their primary care provider;
  • identify the use of long-acting antiretroviral therapy in people with HIV with hepatitis B co-infection.

Presentations:

  • 1:45 PM - 2:03 PM US ET
    Who's on First? The Primary Provider for PWH: HIV Specialist or a Generalist? Internist

    Debate Style Speaker: Christopher Evans, MD (he/him/his) – Oregon Health & Science University

  • 2:03 PM - 2:21 PM US ET
    Who's on First? The Primary Provider for PWH: HIV Specialist or a Generalist? HIV/ID Specialist

    Debate Style Speaker: Barbara S. Taylor, MD, MS (she/her/hers) – UT San Antonio, Long School of Medicine

  • 2:21 PM - 2:39 PM US ET
    Is Hepatitis B a Contraindication to Use of Long-Acting ART? Pro

    Debate Style Speaker: Claudia Hawkins, MD, MPH – Northwestern University Feinberg School of Medicine

  • 2:39 PM - 3:00 PM US ET
    Is Hepatitis B a Contraindication to Use of Long-Acting ART? Con

    Debate Style Speaker: Debika Bhattacharya, MD MSc – David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California